Načítá se...
Gene Therapy for Human Sensorineural Hearing Loss
Hearing loss is the most common sensory impairment in humans and currently disables 466 million people across the world. Congenital deafness affects at least 1 in 500 newborns, and over 50% are hereditary in nature. To date, existing pharmacologic therapies for genetic and acquired etiologies of dea...
Uloženo v:
| Vydáno v: | Front Cell Neurosci |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660246/ https://ncbi.nlm.nih.gov/pubmed/31379508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00323 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|